When managing persistent chest pain in STEMI patients who have already received standard therapy, you need to focus on safe, effective pain relief that won't compromise hemodynamics or worsen the cardiac condition.

Option D (Fentanyl 50 mcg IV) is correct because opioid analgesia is the standard of care for persistent ischemic chest pain after nitrates have failed. Fentanyl effectively reduces pain and anxiety without significantly affecting blood pressure or heart rate. Pain relief is crucial in STEMI because continued pain indicates ongoing ischemia and increases sympathetic stimulation, which raises myocardial oxygen demand.

Option A is wrong because fluid boluses can worsen heart failure and pulmonary edema in STEMI patients. The patient's BP of 110/70 is adequate for coronary perfusion, and volume loading could be dangerous.

Option B is incorrect because while beta-blockers reduce oxygen demand, they're contraindicated in acute STEMI with ongoing chest pain until the patient is stabilized. The relatively normal heart rate (90 bpm) and borderline BP make metoprolol risky at this stage.

Option C is wrong because prophylactic lidocaine is no longer recommended in STEMI management. Current guidelines show it doesn't improve outcomes and may increase mortality risk.

NREMT strategy: In cardiac emergency questions, prioritize immediate symptom relief and hemodynamic stability. When standard treatments (aspirin, nitrates) fail for chest pain, opioid analgesia is your next step. Avoid interventions that could destabilize blood pressure or heart function in acute cardiac patients.

This patient has a stable supraventricular tachycardia (SVT). According to ACLS guidelines, the first-line treatment for stable SVT is attempting vagal maneuvers. Instructing the patient to bear down (the Valsalva maneuver) is a common and effective vagal maneuver. If this fails, then pharmacological intervention with adenosine would be the next step. Cardioversion is reserved for unstable patients.

This patient's presentation (sudden onset dyspnea, pleuritic pain, recent travel, tachycardia, low ETCO2) is highly suggestive of a massive pulmonary embolism (PE). The low ETCO2 reflects a ventilation/perfusion mismatch. Prehospital management is primarily supportive. The most crucial interventions are supplemental oxygen to correct hypoxia and rapid transport to a facility capable of definitive care (thrombolytics or thrombectomy).

In a severe asthma attack, the absence of wheezing (a "silent chest") combined with diminished air movement indicates that the patient is no longer moving enough air to generate sound. This is a pre-terminal sign of complete airway obstruction and impending respiratory arrest. While the other findings are serious, the silent chest is the most immediately life-threatening sign.

This patient is in a hypertensive emergency with signs of end-organ damage (encephalopathy, pulmonary edema). The goal is not to normalize the blood pressure rapidly, as this can cause hypoperfusion and ischemic injury to vital organs. The accepted guideline is to lower the Mean Arterial Pressure (MAP) by 10-20% in the first hour, or a maximum of 25%, using a titratable IV agent like nicardipine or labetalol.

This patient is in florid cardiogenic pulmonary edema, likely secondary to a hypertensive emergency (Sympathetic Crashing Acute Pulmonary Edema - SCAPE). The most effective treatment is to aggressively reduce both preload and afterload. CPAP provides immediate respiratory support and helps drive fluid out of the alveoli, while a high-dose IV nitroglycerin infusion will cause vasodilation, reducing the workload on the failing left ventricle.

Myasthenia gravis is an autoimmune disorder that affects the neuromuscular junction, leading to muscle weakness. A myasthenic crisis is a life-threatening exacerbation where the weakness affects the muscles of respiration, including the diaphragm and intercostals. This leads to hypoventilation and respiratory failure. The primary problem is neuromuscular fatigue, not bronchoconstriction, pulmonary edema, or upper airway obstruction.

The patient is in post-arrest cardiogenic shock, confirmed by the extensive anterior STEMI. The hypotension is due to pump failure, not volume loss. While a small fluid challenge might be considered, a vasopressor is necessary. Norepinephrine is the first-line agent for cardiogenic shock as it increases systemic vascular resistance and has some inotropic effects, improving perfusion without significantly increasing heart rate. A large epinephrine bolus would cause excessive tachycardia and increase myocardial oxygen demand. Pacing is not indicated for hypotension with an adequate heart rate.

The key finding is the pericardial friction rub, described as a triphasic, grating, or scratching sound. This sound, combined with pleuritic chest pain that is relieved by leaning forward, is pathognomonic for acute pericarditis. Autoimmune diseases like lupus are a known cause of pericarditis. The other options do not typically present with a friction rub.

When treating anaphylaxis, you must address multiple systems simultaneously - cardiovascular collapse, respiratory compromise, and inflammatory responses. After epinephrine administration, persistent bronchospasm requires targeted respiratory intervention as your immediate priority.

Answer D is correct because albuterol is a beta-2 agonist that directly targets bronchial smooth muscle constriction. While epinephrine has beta-2 effects, its primary role in anaphylaxis is cardiovascular support through alpha-1 and beta-1 stimulation. Continuous albuterol nebulization provides sustained bronchodilation specifically for the respiratory component of this patient's deteriorating condition.

Answer A is problematic because repeating epinephrine IM won't provide the targeted bronchodilation needed for persistent wheezing. While epinephrine can be repeated every 5-15 minutes, it's not the most effective second-line treatment for isolated bronchospasm after the initial dose.

Answer B represents premature escalation. Although RSI might eventually become necessary, attempting bronchodilation first is appropriate since the patient is still conscious and breathing spontaneously, despite increased work of breathing.

Answer C addresses the histamine-mediated components (urticaria, angioedema) but won't provide immediate relief for bronchospasm. Diphenhydramine is important in anaphylaxis management but works too slowly for acute respiratory distress.

Study tip: In anaphylaxis questions, remember the treatment hierarchy: epinephrine first for systemic effects, then target specific persistent symptoms with appropriate medications. Bronchospasm after epinephrine calls for beta-2 agonists, not more epinephrine or immediate intubation.